The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review

The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review

Single-nucleotide polymorphisms (SNPs) play an essential role in various malignancies, but their role in cholangiocarcinoma (CCA) remains to be elucidated. Therefore, the purpose of this systematic review was to evaluate the association between SNPs and CCA, focusing on tumorigenesis and prognosis....

Full description

Bibliographic Details
Main Authors:	Guanwu Wang, Lara Rosaline Heij, Dong Liu, Edgar Dahl, Sven Arke LANG, Tom Florian Ulmer, Tom LUEDDE, Ulf Peter Neumann, Jan Bednarsch
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Cancers
Subjects:	cholangiocarcinoma single-nucleotide polymorphism (SNP) cancer progression cancer susceptibility prognosis systematic review
Online Access:	https://www.mdpi.com/2072-6694/14/23/5969

Similar Items

Compelling Long-Term Results for Liver Resection in Early Cholangiocarcinoma
by: Jan Bednarsch, et al.
Published: (2021-06-01)

Leakage and Stenosis of the Hepaticojejunostomy Following Surgery for Perihilar Cholangiocarcinoma
by: Jan Bednarsch, et al.
Published: (2020-05-01)

Impact of Altered Body Composition on Clinical and Oncological Outcomes in Intrahepatic Cholangiocarcinoma
by: Guanwu Wang, et al.
Published: (2023-12-01)

Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
by: Christoph Roderburg, et al.
Published: (2021-06-01)

The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma
by: Jan Bednarsch, et al.
Published: (2021-07-01)

Preoperative predictors for non-resectability in perihilar cholangiocarcinoma
by: Carlos Constantin Otto, et al.
Published: (2024-02-01)

Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
by: Lara Heij, et al.
Published: (2023-03-01)

The Value of Platelet-to-Lymphocyte Ratio as a Prognostic Marker in Cholangiocarcinoma: A Systematic Review and Meta-Analysis
by: Dong Liu, et al.
Published: (2022-01-01)

PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma
by: Xiuxiang Tan, et al.
Published: (2022-04-01)

Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery
by: Anna Mantas, et al.
Published: (2024-01-01)

Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer
by: Sven H. Loosen, et al.
Published: (2022-08-01)

Single Nucleotide Polymorphisms in microRNA Genes and Colorectal Cancer Risk and Prognosis
by: Maria Radanova, et al.
Published: (2022-01-01)

Body composition is associated with postoperative complications in perihilar cholangiocarcinoma
by: Guanwu Wang, et al.
Published: (2024-01-01)

Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma
by: Georgios Charalampopoulos, et al.
Published: (2023-06-01)

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
by: Gennaro Gadaleta-Caldarola, et al.
Published: (2022-10-01)

Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
by: Alessandro Rizzo, et al.
Published: (2020-11-01)

Role of Chemokines in the Biology of Cholangiocarcinoma
by: Alessandra Caligiuri, et al.
Published: (2020-08-01)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
by: Sven H. Loosen, et al.
Published: (2022-09-01)

Immune microenvironment and progress in immunotherapy of cholangiocarcinoma
by: Xinyu Shao
Published: (2023-12-01)

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
by: Joon Hyuk Choi, et al.
Published: (2022-07-01)

Double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma
by: Yi-Hsuan Hu, et al.
Published: (2020-01-01)

Can Previous Associations of Single Nucleotide Polymorphisms in the <i>TLR2</i>, <i>NOD1</i>, <i>CXCR5</i>, and <i>IL10</i> Genes in the Susceptibility to and Severity of <i>Chlamydia trachomatis</i> Infections Be Confirmed?
by: Jelmer B. Jukema, et al.
Published: (2021-01-01)

Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
by: Kishor Pant, et al.
Published: (2020-03-01)

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
by: Jihye L. Golino, et al.
Published: (2023-04-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Limitations of Nerve Fiber Density as a Prognostic Marker in Predicting Oncological Outcomes in Hepatocellular Carcinoma
by: Jan Bednarsch, et al.
Published: (2022-04-01)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
by: Amram Kupietzky, et al.
Published: (2022-12-01)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
by: Timo Alexander Auer, et al.
Published: (2023-05-01)

Diagnosis of Cholangiocarcinoma
by: Dong Woo Shin, et al.
Published: (2023-01-01)

Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
by: Su Min Cho, et al.
Published: (2022-05-01)

The Impact of a Preoperative Staging System on Accurate Prediction of Prognosis in Intrahepatic Cholangiocarcinoma
by: Hisashi Kosaka, et al.
Published: (2022-02-01)

Cholangiocarcinoma in the Era of Immunotherapy
by: Eleni Manthopoulou, et al.
Published: (2023-06-01)

Editorial: Targeting nucleotide metabolism for enhancing antitumor immunity
by: Jun Wu, et al.
Published: (2024-04-01)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
by: Oraianthi Fiste, et al.
Published: (2021-04-01)

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation
by: Kyaw Zwar Myint, et al.
Published: (2024-02-01)

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma
by: Brinda Balasubramanian, et al.
Published: (2022-07-01)

The Role of HOX Transcription Factors in Cancer Predisposition and Progression
by: Bo Li, et al.
Published: (2019-04-01)

Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019
by: Sarah Krieg, et al.
Published: (2022-04-01)

Flanking monomer repeats define lower context complexity of sites containing single nucleotide polymorphisms in the human genome
by: N. S. Safronova, et al.
Published: (2016-01-01)

Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
by: Eliza W. Beal, et al.
Published: (2020-12-01)